Drugs / Hydrocodone Bitartrate Extended Release
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02126917 | Nov → Dec 2009 | — | Zogenix, Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02222740 | Sep → Dec 2002 | osteoarthritis | Zogenix, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hydrocodone Bitartrate Extended Release | “Hydrocodone Bitartrate Extended-Release (HC-ER) Capsules 50 mg” NCT02126917 ↗ |
| Known as | HC-ER | “Hydrocodone Bitartrate Extended-Release (HC-ER) Capsules 50 mg” NCT02126917 ↗1“Hydrocodone Bitartrate Extended Release (HC-ER)” NCT02222740 ↗ |